Iskalni niz je ali predolg ali pa vsebuje preveč besed.
Prevodi: en > sl
51–59/59
ratio scale
51 Prevajalska redakcija
RS
EMEA
Regarding the qualification of “ severe aggression”, the CHMP considered that rating scales were not practical in clinical settings and that the most important clinical criteria to be met before treatment is initiated is that the aggression places the person or carer at risk of harm and that the behaviour is persistent.
Glede opredelitve „ hude agresivnosti “ je CHMP menil, da ocenjevalne lestvice v kliničnem okolju niso praktične ter da je najpomembnejše klinično merilo, ki mora biti izpolnjeno pred pričetkom zdravljenja, izraz agresivnosti, ki ogroža posameznika ali skrbnika, ter da je takšno vedenje trajno.
52 Prevajalska redakcija
RS
EMEA
Risperidone showed statistically significant and clinically important effectiveness in treating aggression and less consistently in treating agitation and psychosis in elderly dementia patients (as measured by the Behavioural Pathology in Alzheimer’ s Disease Rating Scale [ BEHAVE-AD ] and the Cohen-Mansfield Agitation Inventory [ CMAI ]).
Risperidon je bil statistično značilno boljši in klinično pomembnejši pri zdravljenju agresije, in manj uspešen pri zdravljenju agitacije in psihoze pri starejših bolnikih z demenco (merjeno po BEHAVE- AD (Behavioural Pathology in Alzheimer’ s Disease) in CMAI (Cohen- Mansfield Agitation Inventory lestvici).
53 Prevajalska redakcija
izobraževanje
CELEX: 31999D0323
The scale of contributions by the Member States concerned shall be calculated annually, taking into account the other States' contributions, on the basis of the ratio of the VAT resources paid by each of those Member States to the total VAT resources of the European Communities, as established in the last amendment of the budget of the Communities during the preceding financial year.
Višina prispevkov teh držav članic se izračuna letno ob upoštevanju prispevkov drugih držav na podlagi razmerja sredstev DDV, ki jih je vsaka teh držav plačala v skupna sredstva DDV Evropskih skupnosti, kot je bilo določeno v zadnji spremembi proračuna Skupnosti med predhodnim finančnim letom.
54 Prevajalska redakcija
izobraževanje
CELEX: 32000D0265
The scale of contributions by the Member States concerned shall be calculated annually, taking into account the contributions of Iceland and Norway, on the basis of the ratio of the VAT resources paid by each of those Member States to the total VAT resources of the European Communities, as established in the last amendment of the budget of the Union during the preceding financial year.
Višina prispevkov zadevnih držav članic se izračuna letno, ob upoštevanju prispevkov Islandije in Norveške, na podlagi razmerja sredstev DDV, ki jih je vsaka zadevna država plačala v skupna sredstva DDV Evropskih skupnosti, kakor je bilo določeno v zadnji spremembi proračuna Skupnosti med predhodnim proračunskim letom.
55 Prevajalska redakcija
RS
EMEA
In a multinational, double-blind, comparative study of schizophrenia, schizoaffective, and related disorders which included 1,481 patients with varying degrees of associated depressive symptoms (baseline mean of 16.6 on the Montgomery-Asberg Depression Rating Scale), a prospective secondary analysis of baseline to endpoint mood score change demonstrated a statistically significant improvement (p=0.001) favouring olanzapine (-6.0) versus haloperidol (-3.1).
V dvojno slepi primerjalni študiji shizofrenije, shizoafektivnih in sorodnih motenj, v kateri je sodelovalo več držav in je vključevala 1481 bolnikov z različnimi stopnjami pridruženih depresivnih simptomov (izhodiščna srednja vrednost 16, 6 na Montgomery- Asbergovi lestvici ocenjevanja depresije), je prospektivna sekundarna analiza spremembe od izhodiščne do končne ocene razpoloženja pokazala statistično značilno izboljšanje (p = 0, 001) v korist olanzapina (– 6, 0) v primerjavi s haloperidolom (– 3, 1).
56 Prevajalska redakcija
RS
EMEA
In a multinational, double-blind, comparative study of schizophrenia, schizoaffective, and related disorders which included 1,481 patients with varying degrees of associated depressive symptoms (baseline mean of 16.6 on the Montgomery-Asberg Depression Rating Scale), a prospective secondary analysis of baseline to endpoint mood score change demonstrated a statistically significant improvement (p= 0.001) favouring olanzapine (-6.0) versus haloperidol (-3.1).
V dvojno slepi primerjalni študiji shizofrenije, shizoafektivnih in sorodnih motenj, v kateri je sodelovalo ve držav in je vklju evala 1481 bolnikov z razli nimi stopnjami pridruženih depresivnih simptomov (izhodiš na srednja vrednost 16, 6 na Montgomery- Asbergovi lestvici ocenjevanja depresije), je prospektivna sekundarna analiza spremembe od izhodiš ne do kon ne ocene razpoloženja pokazala statisti no zna ilno izboljšanje (p = 0, 001) v korist olanzapina (– 6, 0) v primerjavi s haloperidolom (– 3, 1).
57 Prevajalska redakcija
RS
EMEA
109 In a multinationational, double-blind, comparative study of schizophrenia, schizoaffective, and related disorders which included 1,481 patients with varying degrees of associated depressive symptoms (baseline mean of 16.6 on the Montgomery-Asberg Depression Rating Scale), a prospective secondary analysis of baseline to endpoint mood score change demonstrated a statistically significant improvement (p=0.001) favouring olanzapine (-6.0) versus haloperidol (-3.1).
simptomov (izhodišna srednja vrednost 16, 6 na Montgomery- Asbergovi lestvici ocenjevanja č depresije), je prospektivna sekundarna analiza spremembe od izhodišne do konč ocenene razpolož pokazala statistič znač izboljš (p = 0, 001) v korist olanzapina (– 6) v primerjavi
58 Prevajalska redakcija
RS
EMEA
A large scale mortality trial (ASSENT II) in approx. 17,000 patients showed that tenecteplase is therapeutically equivalent to alteplase in reducing mortality (6.2 % for both treatments, at 30 days, upper limit of the 95 % CI for the relative risk ratio 1.124) and that the use of tenecteplase is associated with a significantly lower incidence of non-intracranial bleedings (26.4 % vs. 28.9 %, p=0.0003). This translates into a significantly lower need of transfusions (4.3 % vs.
Velika raziskava o umrljivosti (ASSENT II), ki je zajela približno 17. 000 bolnikov, je pokazala, da je tenekteplaza glede na zmanjšanje umrljivosti terapevtično enakovredna alteplazi (6, 2 % pri obeh zdravilih po 30 dneh, zgornja meja 95- odstotnega intervala zaupanja za relativno razmerje tveganja je 1, 124) in da je pri zdravljenju s tenekteplazo pomembno manjša pogostnost nemožganskih krvavitev (26, 4 % proti 28, 9 %; p = 0, 0003).
59 Prevod
promet
CELEX: 22002A1213(01)
The arithmetic average of the 10 years shall be weighted on a decreasing linear scale, so that the ratio of the relevant year shall have a weight of 10, the year prior to the relevant ye ar shall have a weight of nine, the next preceding year shall have a weight of eight, and so on, until the 10th year has a weight of one.
Aritmetično povprečje 10 let se ponderira po padajoči linearni lestvici, tako da ima razmerje ustreznega leta faktor ponderiranja 10, leto pred ustreznim letom ima faktor ponderiranja devet, naslednje predhodno leto ima faktor ponderiranja osem, in tako naprej, do 10. leta, ki ima faktor ponderiranja 1.
Prevodi: en > sl
51–59/59
ratio scale